Literature DB >> 24646451

Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition.

Julie A Schmidt1, Naomi E Allen1, Martin Almquist1, Silvia Franceschi1, Sabina Rinaldi1, Sarah J Tipper1, Konstantinos K Tsilidis1, Elisabete Weiderpass1, Kim Overvad1, Anne Tjønneland1, Marie-Christine Boutron-Ruault1, Laure Dossus1, Sylvie Mesrine1, Rudolf Kaaks1, Annekatrin Lukanova1, Heiner Boeing1, Pagona Lagiou1, Dimitrios Trichopoulos1, Antonia Trichopoulou1, Domenico Palli1, Vittorio Krogh1, Salvatore Panico1, Rosario Tumino1, Roberto Zanetti1, H Bas Bueno-de-Mesquita1, Petra H Peeters1, Eiliv Lund1, Virginia Menéndez1, Antonio Agudo1, María-José Sánchez1, Maria-Dolores Chirlaque1, Eva Ardanaz1, Nerea Larrañaga1, Joakim Hennings1, Maria Sandström1, Kay-Tee Khaw1, Nick Wareham1, Isabelle Romieu1, Marc J Gunter1, Elio Riboli1, Timothy J Key1, Ruth C Travis1.   

Abstract

BACKGROUND: Little is known about the causes of thyroid cancer, but insulin-like growth factor-I (IGF-I) might play an important role in its development due to its mitogenic and antiapoptotic properties.
METHODS: This study prospectively investigated the association between serum IGF-I concentrations and risk of differentiated thyroid carcinoma in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition. The 345 incident cases of differentiated thyroid carcinoma were individually matched to 735 controls by study center, sex and age, date, time, and fasting status at blood collection, follow-up duration, and for women menopausal status, use of exogenous hormones, and phase of menstrual cycle at blood collection. Serum IGF-I concentrations were measured by immunoassay, and risk of differentiated thyroid cancer in relation to IGF-I concentration was estimated using conditional logistic regression.
RESULTS: There was a positive association between IGF-I concentrations and risk of differentiated thyroid carcinoma: the OR for a doubling in IGF-I concentration was 1.48 (95% confidence interval, 1.06-2.08; Ptrend = 0.02). The positive association with IGF-I was stable over time between blood collection and cancer diagnosis.
CONCLUSION: These findings suggest that IGF-I concentrations may be positively associated with risk of differentiated thyroid carcinoma. IMPACT: This study provides the first prospective evidence of a potential association between circulating IGF-I concentrations and risk of differentiated thyroid carcinoma and may prompt the further investigations needed to confirm the association. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24646451      PMCID: PMC4046912          DOI: 10.1158/1055-9965.EPI-13-1210-T

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  40 in total

1.  Discovery of common variants associated with low TSH levels and thyroid cancer risk.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Jon G Jonasson; Gisli Masson; Huiling He; Aslaug Jonasdottir; Asgeir Sigurdsson; Simon N Stacey; Hrefna Johannsdottir; Hafdis Th Helgadottir; Wei Li; Rebecca Nagy; Matthew D Ringel; Richard T Kloos; Marieke C H de Visser; Theo S Plantinga; Martin den Heijer; Esperanza Aguillo; Angeles Panadero; Enrique Prats; Almudena Garcia-Castaño; Ana De Juan; Fernando Rivera; G Bragi Walters; Hjordis Bjarnason; Laufey Tryggvadottir; Gudmundur I Eyjolfsson; Unnur S Bjornsdottir; Hilma Holm; Isleifur Olafsson; Kristleifur Kristjansson; Hoskuldur Kristvinsson; Olafur T Magnusson; Gudmar Thorleifsson; Jeffrey R Gulcher; Augustine Kong; Lambertus A L M Kiemeney; Thorvaldur Jonsson; Hannes Hjartarson; Jose I Mayordomo; Romana T Netea-Maier; Albert de la Chapelle; Jon Hrafnkelsson; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2012-01-22       Impact factor: 38.330

2.  Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis.

Authors:  Richard J Q McNally; Karen Blakey; Peter W James; Basilio Gomez Pozo; Nermine O Basta; Juliet Hale
Journal:  Eur J Epidemiol       Date:  2012-07-04       Impact factor: 8.082

3.  Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Rudolf Kaaks; Franco Berrino; Timothy Key; Sabina Rinaldi; Laure Dossus; Carine Biessy; Giorgio Secreto; Pilar Amiano; Sheila Bingham; Heiner Boeing; H Bas Bueno de Mesquita; Jenny Chang-Claude; Françoise Clavel-Chapelon; Agnès Fournier; Carla H van Gils; Carlos A Gonzalez; Aurelio Barricarte Gurrea; Elena Critselis; Kay Tee Khaw; Vittorio Krogh; Petra H Lahmann; Gabriele Nagel; Anja Olsen; N Charlotte Onland-Moret; Kim Overvad; Domenico Palli; Salvatore Panico; Petra Peeters; J Ramón Quirós; Andrew Roddam; Anne Thiebaut; Anne Tjønneland; Ma Dolores Chirlaque; Antonia Trichopoulou; Dimitrios Trichopoulos; Rosario Tumino; Paolo Vineis; Teresa Norat; Pietro Ferrari; Nadia Slimani; Elio Riboli
Journal:  J Natl Cancer Inst       Date:  2005-05-18       Impact factor: 13.506

Review 4.  Iodine and cancer.

Authors:  U Feldt-Rasmussen
Journal:  Thyroid       Date:  2001-05       Impact factor: 6.568

5.  Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.

Authors:  Dana E Rollison; Craig J Newschaffer; Yuzhen Tao; Michael Pollak; Kathy J Helzlsouer
Journal:  Int J Cancer       Date:  2006-03-01       Impact factor: 7.396

6.  Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

Authors:  R Kaaks; P Toniolo; A Akhmedkhanov; A Lukanova; C Biessy; H Dechaud; S Rinaldi; A Zeleniuch-Jacquotte; R E Shore; E Riboli
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

7.  What does the odds ratio estimate in a case-control study?

Authors:  N Pearce
Journal:  Int J Epidemiol       Date:  1993-12       Impact factor: 7.196

8.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.

Authors:  E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci
Journal:  Public Health Nutr       Date:  2002-12       Impact factor: 4.022

9.  Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study.

Authors:  Sabina Rinaldi; Mauro Lise; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Gwenaelle Guillas; Kim Overvad; Anne Tjønneland; Jytte Halkjær; Annekatrin Lukanova; Rudolf Kaaks; Manuela M Bergmann; Heiner Boeing; Antonia Trichopoulou; Dimosthenis Zylis; Elissavet Valanou; Domenico Palli; Claudia Agnoli; Rosario Tumino; Silvia Polidoro; Amalia Mattiello; H Bas Bueno-de-Mesquita; Petra H Peeters; Elisabete Weiderpass; Eiliv Lund; Guri Skeie; Laudina Rodríguez; Noemie Travier; Maria-José Sánchez; Pilar Amiano; José-María Huerta; Eva Ardanaz; Torgny Rasmuson; Göran Hallmans; Martin Almquist; Jonas Manjer; Konstantinos K Tsilidis; Naomi E Allen; Kay-Tee Khaw; Nick Wareham; Graham Byrnes; Isabelle Romieu; Elio Riboli; Silvia Franceschi
Journal:  Int J Cancer       Date:  2012-05-14       Impact factor: 7.396

10.  Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.

Authors:  Timothy J Key; Paul N Appleby; Gillian K Reeves; Andrew W Roddam
Journal:  Lancet Oncol       Date:  2010-05-14       Impact factor: 41.316

View more
  20 in total

1.  Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies.

Authors:  Cari M Kitahara; Marjorie L McCullough; Silvia Franceschi; Sabina Rinaldi; Alicja Wolk; Gila Neta; Hans Olov Adami; Kristin Anderson; Gabriella Andreotti; Laura E Beane Freeman; Leslie Bernstein; Julie E Buring; Francoise Clavel-Chapelon; Lisa A De Roo; Yu-Tang Gao; J Michael Gaziano; Graham G Giles; Niclas Håkansson; Pamela L Horn-Ross; Vicki A Kirsh; Martha S Linet; Robert J MacInnis; Nicola Orsini; Yikyung Park; Alpa V Patel; Mark P Purdue; Elio Riboli; Kimberly Robien; Thomas Rohan; Dale P Sandler; Catherine Schairer; Arthur B Schneider; Howard D Sesso; Xiao-Ou Shu; Pramil N Singh; Piet A van den Brandt; Elizabeth Ward; Elisabete Weiderpass; Emily White; Yong-Bing Xiang; Anne Zeleniuch-Jacquotte; Wei Zheng; Patricia Hartge; Amy Berrington de González
Journal:  Thyroid       Date:  2016-02       Impact factor: 6.568

2.  Causal associations of autoimmune thyroiditis and papillary thyroid carcinoma: mRNA expression of selected nuclear receptors and other molecular targets.

Authors:  Dana Macejova; Jan Podoba; Lucia Toporova; Marianna Grigerova; Karol Kajo; Katarina Machalekova; Julius Brtko
Journal:  Oncol Lett       Date:  2019-08-22       Impact factor: 2.967

3.  Fetal growth and subsequent maternal risk of thyroid cancer.

Authors:  Casey Crump; Jan Sundquist; Weiva Sieh; Marilyn A Winkleby; Kristina Sundquist
Journal:  Int J Cancer       Date:  2015-10-05       Impact factor: 7.396

4.  Epidemiology of Thyroid Cancer.

Authors:  Cari M Kitahara; Arthur B Schneider
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

Review 5.  IGF Bioregulation System in Benign and Malignant Thyroid Nodular Disease: A Systematic Review.

Authors:  Apostolos Karagiannis; Eva Kassi; Antonios Chatzigeorgiou; Michael Koutsilieris
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

6.  Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study.

Authors:  Raul Zamora-Ros; Sabina Rinaldi; Konstantinos K Tsilidis; Elisabete Weiderpass; Marie-Christine Boutron-Ruault; Agnetha Linn Rostgaard-Hansen; Anne Tjønneland; Françoise Clavel-Chapelon; Sylvie Mesrine; Verena A Katzke; Tilman Kühn; Jana Förster; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Eleni Klinaki; Giovanna Masala; Sabina Sieri; Fulvio Ricceri; Rosario Tumino; Amalia Mattiello; Petra H M Peeters; H B As Bueno-de-Mesquita; Dagrun Engeset; Guri Skeie; Marcial Argüelles; Antonio Agudo; María-José Sánchez; María-Dolores Chirlaque; Aurelio Barricarte; Saioa Chamosa; Martin Almquist; Ada Tosovic; Joakim Hennings; Maria Sandström; Julie A Schmidt; Kay-Thee Khaw; Nicholas J Wareham; Amanda J Cross; Nadia Slimani; Graham Byrnes; Isabelle Romieu; Elio Riboli; Silvia Franceschi
Journal:  Int J Cancer       Date:  2015-07-30       Impact factor: 7.396

7.  Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study.

Authors:  Cari M Kitahara; Dagrun Slettebø Daltveit; Anders Ekbom; Anders Engeland; Mika Gissler; Ingrid Glimelius; Tom Grotmol; Ylva Trolle Lagerros; Laura Madanat-Harjuoja; Tuija Männistö; Henrik Toft Sørensen; Rebecca Troisi; Tone Bjørge
Journal:  Lancet Diabetes Endocrinol       Date:  2020-12-18       Impact factor: 32.069

Review 8.  Adiponectin and Thyroid Cancer: Insight into the Association between Adiponectin and Obesity.

Authors:  Yuanyuan Zhou; Ying Yang; Taicheng Zhou; Bai Li; Zhanjian Wang
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

Review 9.  Recurrence of differentiated thyroid carcinoma during full TSH suppression: is the tumor now thyroid hormone dependent?

Authors:  Paul J Davis; Aleck Hercbergs; Mary K Luidens; Hung-Yun Lin
Journal:  Horm Cancer       Date:  2014-10-08       Impact factor: 3.869

10.  Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-Specific Cancers: Cohort Study Analyses from the UK Biobank.

Authors:  Frank Qian; Dezheng Huo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-08-20       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.